[Experience with high-dose methotrexate therapy for malignant solid tumors]. 1982

K Kawai, and T Shibata, and E Azuma, and S Arai, and C Nakano, and S Hirai, and K Kazuoka, and Y Komada, and T Nakabayashi, and H Hirota, and T Matsuda, and S Shimizu, and T Nobori, and M Inoue, and H Kamiya, and M Sakurai, and T Ogiwara, and Y Kawabe, and T Nomura, and M Kato, and A Uejima

Thirteen patients with malignant solid tumors, mainly osteogenic sarcomas, were treated by high-dose MTX therapy, 50-400 mg/kg, in a total of 72 cycles. It has been proved that this therapy was relatively safe provided careful clinical surveillance were assured. Of 8 patients with osteogenic sarcomas, 6 had no metastatic lesions on the chest X-rays before this therapy: three were alive without any evidence of disease for 18-25 months after high-dose MTX therapy. In some cases of other malignant solid tumors, particularly intracranial tumors, clinical efficacy was observed. Dose-time relationships, etc. should further be studied for more therapeutic efficacies of high-dose MTX therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011149 Pons The front part of the hindbrain (RHOMBENCEPHALON) that lies between the MEDULLA and the midbrain (MESENCEPHALON) ventral to the cerebellum. It is composed of two parts, the dorsal and the ventral. The pons serves as a relay station for neural pathways between the CEREBELLUM to the CEREBRUM. Pons Varolii,Ponte,Pons Varolius,Pontes,Varolii, Pons,Varolius, Pons
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell

Related Publications

K Kawai, and T Shibata, and E Azuma, and S Arai, and C Nakano, and S Hirai, and K Kazuoka, and Y Komada, and T Nakabayashi, and H Hirota, and T Matsuda, and S Shimizu, and T Nobori, and M Inoue, and H Kamiya, and M Sakurai, and T Ogiwara, and Y Kawabe, and T Nomura, and M Kato, and A Uejima
January 1977, Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology,
K Kawai, and T Shibata, and E Azuma, and S Arai, and C Nakano, and S Hirai, and K Kazuoka, and Y Komada, and T Nakabayashi, and H Hirota, and T Matsuda, and S Shimizu, and T Nobori, and M Inoue, and H Kamiya, and M Sakurai, and T Ogiwara, and Y Kawabe, and T Nomura, and M Kato, and A Uejima
March 1966, Bruns' Beitrage fur klinische Chirurgie,
K Kawai, and T Shibata, and E Azuma, and S Arai, and C Nakano, and S Hirai, and K Kazuoka, and Y Komada, and T Nakabayashi, and H Hirota, and T Matsuda, and S Shimizu, and T Nobori, and M Inoue, and H Kamiya, and M Sakurai, and T Ogiwara, and Y Kawabe, and T Nomura, and M Kato, and A Uejima
January 1976, Medical and pediatric oncology,
K Kawai, and T Shibata, and E Azuma, and S Arai, and C Nakano, and S Hirai, and K Kazuoka, and Y Komada, and T Nakabayashi, and H Hirota, and T Matsuda, and S Shimizu, and T Nobori, and M Inoue, and H Kamiya, and M Sakurai, and T Ogiwara, and Y Kawabe, and T Nomura, and M Kato, and A Uejima
October 1978, Harefuah,
K Kawai, and T Shibata, and E Azuma, and S Arai, and C Nakano, and S Hirai, and K Kazuoka, and Y Komada, and T Nakabayashi, and H Hirota, and T Matsuda, and S Shimizu, and T Nobori, and M Inoue, and H Kamiya, and M Sakurai, and T Ogiwara, and Y Kawabe, and T Nomura, and M Kato, and A Uejima
October 1983, Nihon Gan Chiryo Gakkai shi,
K Kawai, and T Shibata, and E Azuma, and S Arai, and C Nakano, and S Hirai, and K Kazuoka, and Y Komada, and T Nakabayashi, and H Hirota, and T Matsuda, and S Shimizu, and T Nobori, and M Inoue, and H Kamiya, and M Sakurai, and T Ogiwara, and Y Kawabe, and T Nomura, and M Kato, and A Uejima
January 1994, Medical oncology (Northwood, London, England),
K Kawai, and T Shibata, and E Azuma, and S Arai, and C Nakano, and S Hirai, and K Kazuoka, and Y Komada, and T Nakabayashi, and H Hirota, and T Matsuda, and S Shimizu, and T Nobori, and M Inoue, and H Kamiya, and M Sakurai, and T Ogiwara, and Y Kawabe, and T Nomura, and M Kato, and A Uejima
January 1998, Medical and pediatric oncology,
K Kawai, and T Shibata, and E Azuma, and S Arai, and C Nakano, and S Hirai, and K Kazuoka, and Y Komada, and T Nakabayashi, and H Hirota, and T Matsuda, and S Shimizu, and T Nobori, and M Inoue, and H Kamiya, and M Sakurai, and T Ogiwara, and Y Kawabe, and T Nomura, and M Kato, and A Uejima
March 1971, Klinicheskaia meditsina,
K Kawai, and T Shibata, and E Azuma, and S Arai, and C Nakano, and S Hirai, and K Kazuoka, and Y Komada, and T Nakabayashi, and H Hirota, and T Matsuda, and S Shimizu, and T Nobori, and M Inoue, and H Kamiya, and M Sakurai, and T Ogiwara, and Y Kawabe, and T Nomura, and M Kato, and A Uejima
February 1977, The Medical journal of Australia,
K Kawai, and T Shibata, and E Azuma, and S Arai, and C Nakano, and S Hirai, and K Kazuoka, and Y Komada, and T Nakabayashi, and H Hirota, and T Matsuda, and S Shimizu, and T Nobori, and M Inoue, and H Kamiya, and M Sakurai, and T Ogiwara, and Y Kawabe, and T Nomura, and M Kato, and A Uejima
December 1998, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!